All News

What it's like to live in a world that includes me, yet somehow keeps me out.

As more people in the United States become addicted or face opioid overdoses, health care professionals are starting to take a step back and re-evaluate their prescribing habits.

There have been studies that suggest if individuals speak poorly to a plant, it does not seem to thrive as well as a plant given positive or constructive feedback.

Although genomic profiling successfully identifies those with microsatellite instability status who may benefit from PD-1 inhibitor therapy, a vast amount of women may be missed if they are not also tested for high tumor mutation burden too.

Traveling with breast prostheses presents its own set of challenges; some real and some imagined.

Blincyto (blinatumomab) was granted approval by the Food and Drug Administration (FDA) to treat patients who have B-cell precursor acute lymphoblastic leukemia (ALL), who are in remission but still have minimal residual disease (MRD).

Open-label placebos may indeed have a positive effect on cancer-related fatigue in survivors, according to recent research.

I rolled out of surgery with one fewer testicle, but also as more of a man for openly admitting it.

What do Bill Nye the Science Guy, fashion designer Michael Kors and one very special prostate cancer advocate all have in common? Blue jackets, a runway and the ultimate goal of raising awareness for prostate cancer.

There are productive ways for cancer survivors to live with the ongoing fear of recurrence.

When the fears and anxiety of cancer haunt you, open a window, walk outside and let nature run its course.

If we find ourselves coasting through cancer, it may be time to kick it up a notch.

Sometimes patients may not report side effects to their health care team, in fear of their oncologist taking them off a drug that could prolong their survival.

"I have grown as a person since becoming a cancer survivor," says breast cancer and melanoma survivor Barbara Tako.

The Food and Drug Administration (FDA) granted priority review to the combination use of Opdivo (nivolumab) and Yervoy (ipilimumab) to treat a subgroup of patients with metastatic colorectal cancer.

What happens if your doctor makes a medical mistake, and when is it appropriate to sue?

Many aspects of going through cancer can be overwhelming or difficult to navigate, so it is important that survivors have resources to help them navigate from the point of diagnosis to beyond the moment when their treatment ends.

I hadn't been to the doctor in over two years, but now I was about to meet three new ones in less than a week.

My pain has persisted for years, and it could last forever. But it's a small price to pay to be cancer-free.

When you're fighting for your life, you shouldn't have to worry about going into debt because of cancer-related costs

When roles change over time, use your cancer super powers to help, says melanoma and breast cancer survivor Barbara Tako.

A fun-filled day turned into a stressful night, followed by an even more terrifying morning when I felt a lump

High cholesterol is a huge problem in America today, but are the statin drugs used to control high cholesterol potentially dangerous? Could these medications pose a health risk to cancer patients?

If an oncologist, infusion center nurse or any member of your medical team has asked you a question like that recently, you can thank Dr. Jimmie Holland, a pioneering psychiatrist who died Dec. 24 at the age of 89.

"I saw people in my life go through cancer, but seeing my daughter do it was devastating," he said.

Chemotherapy can aid in making a tumor “hot” – meaning that it attracts tumor-infiltrating lymphocytes (TILs), which are linked to killing tumor cells – priming it to respond better to immunotherapy treatment.

Kevin unleashes his inner guilt for the benefit of you, gentle readers.

The Right-to-Try bill recently passed in the United States House of Representatives.

Tasigna (nilotinib) was granted Food and Drug Administration (FDA) approval, to be used in the first- and second-line setting for pediatric patients 1 year old or older who have Philadelphia chromosome–positive chronic myeloid leukemia in the chronic phase (Ph+ CML-CP).

Take a look at how radiation therapy can impact the future health of your heart.